Atomistry » Iron » PDB 5ug2-5utc » 5urc
Atomistry »
  Iron »
    PDB 5ug2-5utc »
      5urc »

Iron in PDB 5urc: Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease

Protein crystallography data

The structure of Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease, PDB code: 5urc was solved by P.P.Pagare, R.S.Safo, A.Gazi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.32 / 1.85
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 62.642, 83.328, 104.954, 90.00, 90.00, 90.00
R / Rfree (%) 17.9 / 22.3

Iron Binding Sites:

The binding sites of Iron atom in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease (pdb code 5urc). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total 4 binding sites of Iron where determined in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease, PDB code: 5urc:
Jump to Iron binding site number: 1; 2; 3; 4;

Iron binding site 1 out of 4 in 5urc

Go back to Iron Binding Sites List in 5urc
Iron binding site 1 out of 4 in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe202

b:19.0
occ:1.00
FE A:HEM202 0.0 19.0 1.0
C A:CMO201 1.9 17.4 1.0
ND A:HEM202 2.0 18.0 1.0
NB A:HEM202 2.0 16.3 1.0
NA A:HEM202 2.0 17.1 1.0
NC A:HEM202 2.0 17.2 1.0
NE2 A:HIS87 2.0 16.8 1.0
CE1 A:HIS87 3.0 15.9 1.0
C4D A:HEM202 3.0 19.6 1.0
C1C A:HEM202 3.1 17.1 1.0
C1A A:HEM202 3.1 18.8 1.0
C4B A:HEM202 3.1 16.6 1.0
C1D A:HEM202 3.1 18.3 1.0
C1B A:HEM202 3.1 16.9 1.0
C4A A:HEM202 3.1 17.9 1.0
C4C A:HEM202 3.1 17.9 1.0
CD2 A:HIS87 3.1 16.8 1.0
O A:CMO201 3.1 21.8 1.0
CHC A:HEM202 3.4 16.5 1.0
CHA A:HEM202 3.4 20.6 1.0
CHD A:HEM202 3.5 17.2 1.0
CHB A:HEM202 3.5 15.2 1.0
ND1 A:HIS87 4.2 16.5 1.0
CG A:HIS87 4.2 15.5 1.0
C3D A:HEM202 4.3 19.4 1.0
C2A A:HEM202 4.3 19.1 1.0
C2D A:HEM202 4.3 20.4 1.0
C2C A:HEM202 4.3 16.4 1.0
C2B A:HEM202 4.3 16.9 1.0
C3A A:HEM202 4.3 17.9 1.0
C3B A:HEM202 4.3 17.1 1.0
C3C A:HEM202 4.3 17.4 1.0
CE1 A:HIS58 4.5 23.2 1.0
NE2 A:HIS58 4.9 23.6 1.0
CG2 A:VAL62 4.9 17.8 1.0

Iron binding site 2 out of 4 in 5urc

Go back to Iron Binding Sites List in 5urc
Iron binding site 2 out of 4 in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 2 of Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Fe202

b:22.8
occ:1.00
FE B:HEM202 0.0 22.8 1.0
C B:CMO201 1.9 24.1 1.0
NC B:HEM202 2.0 24.2 1.0
NB B:HEM202 2.0 22.3 1.0
NA B:HEM202 2.0 23.2 1.0
ND B:HEM202 2.0 25.3 1.0
NE2 B:HIS92 2.0 21.6 1.0
CE1 B:HIS92 3.0 22.6 1.0
CD2 B:HIS92 3.1 22.1 1.0
C1C B:HEM202 3.1 22.6 1.0
C1D B:HEM202 3.1 25.6 1.0
C4C B:HEM202 3.1 25.2 1.0
C1A B:HEM202 3.1 23.3 1.0
C1B B:HEM202 3.1 20.4 1.0
C4B B:HEM202 3.1 20.9 1.0
C4A B:HEM202 3.1 21.7 1.0
C4D B:HEM202 3.1 25.1 1.0
O B:CMO201 3.1 26.4 1.0
CHC B:HEM202 3.4 21.6 1.0
CHD B:HEM202 3.4 25.9 1.0
CHA B:HEM202 3.4 23.1 1.0
CHB B:HEM202 3.5 20.4 1.0
ND1 B:HIS92 4.2 21.6 1.0
CG B:HIS92 4.2 21.5 1.0
C2A B:HEM202 4.3 21.7 1.0
C2C B:HEM202 4.3 24.2 1.0
C3A B:HEM202 4.3 21.2 1.0
C2D B:HEM202 4.3 27.1 1.0
C3C B:HEM202 4.3 24.4 1.0
C3D B:HEM202 4.3 26.9 1.0
C2B B:HEM202 4.3 19.1 1.0
C3B B:HEM202 4.3 22.4 1.0
CE1 B:HIS63 4.4 23.5 1.0
CG2 B:VAL67 4.9 15.5 1.0

Iron binding site 3 out of 4 in 5urc

Go back to Iron Binding Sites List in 5urc
Iron binding site 3 out of 4 in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 3 of Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Fe202

b:17.6
occ:1.00
FE C:HEM202 0.0 17.6 1.0
C C:CMO201 1.9 16.5 1.0
ND C:HEM202 2.0 16.9 1.0
NA C:HEM202 2.0 17.4 1.0
NE2 C:HIS87 2.0 15.7 1.0
NC C:HEM202 2.0 16.1 1.0
NB C:HEM202 2.0 17.0 1.0
CE1 C:HIS87 3.0 17.2 1.0
C4D C:HEM202 3.0 18.9 1.0
C1D C:HEM202 3.0 17.5 1.0
C1A C:HEM202 3.0 19.9 1.0
CD2 C:HIS87 3.1 18.4 1.0
C1B C:HEM202 3.1 18.0 1.0
C4A C:HEM202 3.1 19.0 1.0
C4C C:HEM202 3.1 17.2 1.0
C1C C:HEM202 3.1 16.2 1.0
C4B C:HEM202 3.1 17.0 1.0
O C:CMO201 3.1 20.4 1.0
CHA C:HEM202 3.4 18.9 1.0
CHD C:HEM202 3.4 18.1 1.0
CHB C:HEM202 3.5 15.5 1.0
CHC C:HEM202 3.5 16.2 1.0
ND1 C:HIS87 4.2 15.7 1.0
CG C:HIS87 4.2 15.3 1.0
C3D C:HEM202 4.2 17.8 1.0
C2D C:HEM202 4.3 17.5 1.0
C2A C:HEM202 4.3 19.3 1.0
C3A C:HEM202 4.3 18.1 1.0
C2B C:HEM202 4.3 17.5 1.0
C2C C:HEM202 4.3 17.2 1.0
C3B C:HEM202 4.3 16.7 1.0
C3C C:HEM202 4.3 17.2 1.0
NE2 C:HIS58 4.6 20.4 1.0
CG2 C:VAL62 4.9 20.3 1.0

Iron binding site 4 out of 4 in 5urc

Go back to Iron Binding Sites List in 5urc
Iron binding site 4 out of 4 in the Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 4 of Design, Synthesis, Functional and Biological Evaluation of Ether and Ester Derivatives of the Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Fe202

b:20.7
occ:1.00
FE D:HEM202 0.0 20.7 1.0
C D:CMO201 1.9 20.7 1.0
ND D:HEM202 2.0 19.7 1.0
NC D:HEM202 2.0 20.6 1.0
NA D:HEM202 2.0 18.9 1.0
NE2 D:HIS92 2.0 19.2 1.0
NB D:HEM202 2.0 18.4 1.0
CE1 D:HIS92 3.0 19.4 1.0
C4D D:HEM202 3.0 20.0 1.0
C1D D:HEM202 3.0 20.8 1.0
C1C D:HEM202 3.1 19.0 1.0
C4A D:HEM202 3.1 18.5 1.0
C1A D:HEM202 3.1 20.1 1.0
C4B D:HEM202 3.1 19.5 1.0
C1B D:HEM202 3.1 19.8 1.0
C4C D:HEM202 3.1 19.0 1.0
CD2 D:HIS92 3.1 20.2 1.0
O D:CMO201 3.1 23.6 1.0
CHC D:HEM202 3.4 18.1 1.0
CHA D:HEM202 3.4 20.0 1.0
CHD D:HEM202 3.4 19.0 1.0
CHB D:HEM202 3.4 19.0 1.0
ND1 D:HIS92 4.2 18.2 1.0
CG D:HIS92 4.2 18.9 1.0
C3D D:HEM202 4.3 20.8 1.0
C2D D:HEM202 4.3 20.9 1.0
C2A D:HEM202 4.3 19.9 1.0
C2C D:HEM202 4.3 18.7 1.0
C3A D:HEM202 4.3 20.4 1.0
C3C D:HEM202 4.3 17.8 1.0
C2B D:HEM202 4.3 21.0 1.0
C3B D:HEM202 4.3 21.8 1.0
CE1 D:HIS63 4.4 17.5 1.0
CG2 D:VAL67 4.8 22.2 1.0

Reference:

G.G.Xu, P.P.Pagare, M.S.Ghatge, R.P.Safo, A.Gazi, Q.Chen, T.David, A.B.Alabbas, F.N.Musayev, J.Venitz, Y.Zhang, M.K.Safo, O.Abdulmalik. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-Hmf For the Treatment of Sickle Cell Disease. Mol. Pharm. V. 14 3499 2017.
ISSN: ESSN 1543-8392
PubMed: 28858508
DOI: 10.1021/ACS.MOLPHARMACEUT.7B00553
Page generated: Tue Aug 6 10:00:09 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy